Cargando…
Design and Solidification of Fast-Releasing Clofazimine Nanoparticles for Treatment of Cryptosporidiosis
[Image: see text] Clofazimine, a lipophilic (log P = 7.66) riminophenazine antibiotic approved by the US Food and Drug Administration (FDA) with a good safety record, was recently identified as a lead hit for cryptosporidiosis through a high-throughput phenotypic screen. Cryptosporidiosis requires f...
Autores principales: | Zhang, Yingyue, Feng, Jie, McManus, Simon A., Lu, Hoang D., Ristroph, Kurt D., Cho, Eugene J., Dobrijevic, Ellen L., Chan, Hak-Kim, Prud’homme, Robert K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2017
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627342/ https://www.ncbi.nlm.nih.gov/pubmed/28929769 http://dx.doi.org/10.1021/acs.molpharmaceut.7b00521 |
Ejemplares similares
-
Rapid Recovery of Clofazimine-Loaded Nanoparticles
with Long-Term Storage Stability as Anti-Cryptosporidium Therapy
por: Feng, Jie, et al.
Publicado: (2018) -
Encapsulation of OZ439 into Nanoparticles for Supersaturated
Drug Release in Oral Malaria Therapy
por: Lu, Hoang D., et al.
Publicado: (2018) -
Solid-State Behavior and Solubilization of Flash Nanoprecipitated
Clofazimine Particles during the Dispersion and Digestion of Milk-Based
Formulations
por: Salim, Malinda, et al.
Publicado: (2019) -
Spray drying OZ439 nanoparticles to form stable, water-dispersible powders for oral malaria therapy
por: Ristroph, Kurt D., et al.
Publicado: (2019) -
Hydrophobic ion pairing: encapsulating small molecules, peptides, and proteins into nanocarriers
por: Ristroph, Kurt D., et al.
Publicado: (2019)